{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:09:47Z","timestamp":1779188987197,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.109863","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T03:49:47Z","timestamp":1590119387000},"page":"109863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Leukocyte immunoglobulin-like receptor subfamily B member 1 potentially acts as a diagnostic and prognostic target in certain subtypes of adenocarcinoma"],"prefix":"10.1016","volume":"144","author":[{"given":"Jianghong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingchun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingchun","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109863_b0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biomaterials.2017.09.017","article-title":"Nanomaterials for cancer immunotherapy","volume":"148","author":"Song","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.mehy.2020.109863_b0010","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mehy.2020.109863_b0015","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1245\/ASO.2005.03.536","article-title":"Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I\/II study","volume":"12","author":"Maker","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.mehy.2020.109863_b0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cllc.2017.02.001","article-title":"Immune checkpoint inhibitors for patients with advanced non-small-cell lung cancer. A systematic review","volume":"18","author":"Ellis","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.mehy.2020.109863_b0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000481245","article-title":"Immuno-oncology in hepatocellular carcinoma: 2017 update","volume":"93","author":"Kudo","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.mehy.2020.109863_b0030","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00262-018-2190-4","article-title":"Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma","volume":"67","author":"Brown","year":"2018","journal-title":"Cancer Immunol Immun"},{"key":"10.1016\/j.mehy.2020.109863_b0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5713\/ajas.18.0561","article-title":"Chicken novel leukocyte immunoglobulin-like receptor subfamilies B1 and B3 are transcriptional regulators of MHC class I genes and signaling pathways","volume":"32","author":"Truong","year":"2019","journal-title":"Asian-Australas J Anim Sci"},{"key":"10.1016\/j.mehy.2020.109863_b0040","doi-asserted-by":"crossref","first-page":"18885","DOI":"10.1073\/pnas.1205785109","article-title":"Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming","volume":"109","author":"Banchereau","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2020.109863_b0045","doi-asserted-by":"crossref","first-page":"17957","DOI":"10.1073\/pnas.1221535110","article-title":"Exocytosis acts as a modulator of the ILT4-mediated inhibition of neutrophil functions","volume":"110","author":"Baudhuin","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2020.109863_b0050","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00262-017-2023-x","article-title":"LILRB receptor-mediated regulation of myeloid cell maturation and function","volume":"66","author":"van der Touw","year":"2017","journal-title":"Cancer Immunol, Immunotherapy: CII"},{"key":"10.1016\/j.mehy.2020.109863_b0055","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.humimm.2013.07.012","article-title":"Upregulation of the inhibitory receptor ILT4 in monocytes from septic patients","volume":"74","author":"Baffari","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.mehy.2020.109863_b0060","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.186.11.1809","article-title":"A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells","volume":"186","author":"Colonna","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2020.109863_b0065","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/leu.2012.62","article-title":"Neoplastic B-cell growth is impaired by HLA-G\/ILT2 interaction","volume":"26","author":"Naji","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.mehy.2020.109863_b0070","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/blood-2003-10-3372","article-title":"Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2","volume":"103","author":"Urosevic","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2020.109863_b0075","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/TP.0b013e318186fccd","article-title":"Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts","volume":"86","author":"Zhang","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.mehy.2020.109863_b0080","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1096\/fj.09-135194","article-title":"ILT2\/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse","volume":"24","author":"Favier","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2020.109863_b0085","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3892\/mmr.2012.744","article-title":"Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance","volume":"5","author":"Zhang","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.mehy.2020.109863_b0090","doi-asserted-by":"crossref","first-page":"21004","DOI":"10.18632\/oncotarget.4217","article-title":"ANGPTL2\/LILRB2 signaling promotes the propagation of lung cancer cells","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mehy.2020.109863_b0095","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s11427-015-4925-1","article-title":"Inhibitory leukocyte immunoglobulin-like receptors in cancer development","volume":"58","author":"Zhang","year":"2015","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.mehy.2020.109863_b0100","first-page":"29","article-title":"Immunostimulatory monoclonal antibodies for hepatocellular carcinoma therapy. Trends and perspectives","volume":"78","author":"Mazzolini","year":"2018","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.mehy.2020.109863_b0105","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.1701622","article-title":"Loss of the immune checkpoint CD85j\/LILRB1 on malignant plasma cells contributes to immune escape in multiple myeloma","volume":"200","author":"Lozano","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2020.109863_b0110","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2010-09-309781","article-title":"Up-regulation of cytolytic functions of human Vdelta2-gamma T lymphocytes through engagement of ILT2 expressed by tumor target cells","volume":"117","author":"Harly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2020.109863_b0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncb3158","article-title":"The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development","volume":"17","author":"Kang","year":"2015","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.mehy.2020.109863_b0120","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1158\/0008-5472.CAN-15-1965","article-title":"Inherent and tumor-driven immune tolerance in the prostate microenvironment impairs natural killer cell antitumor activity","volume":"76","author":"Pasero","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2020.109863_b0125","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2020.109863_b0130","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/eji.201445353","article-title":"Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade","volume":"45","author":"Roberti","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mehy.2020.109863_b0135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/tan.12561","article-title":"Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer","volume":"85","author":"Wisniewski","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.mehy.2020.109863_b0140","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/annonc\/mdx163","article-title":"Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)","volume":"28","author":"Jain","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mehy.2020.109863_b0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10735-014-9597-9","article-title":"ATP5b and beta2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer","volume":"46","author":"Sun","year":"2015","journal-title":"J Mol Histol"},{"key":"10.1016\/j.mehy.2020.109863_b0150","doi-asserted-by":"crossref","first-page":"10656","DOI":"10.1073\/pnas.1100354108","article-title":"HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8(+) T lymphocytes","volume":"108","author":"Gooden","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2020.109863_b0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/path.1039","article-title":"Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer","volume":"196","author":"Lefebvre","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.mehy.2020.109863_b0160","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni961","article-title":"Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor","volume":"4","author":"Willcox","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2020.109863_b0165","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.1431057100","article-title":"Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G","volume":"100","author":"Shiroishi","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2020.109863_b0170","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1002\/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L","article-title":"Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors","volume":"30","author":"Lepin","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mehy.2020.109863_b0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-1759(02)00199-0","article-title":"Tetrameric complexes of HLA-E, HLA-F, and HLA-G","volume":"268","author":"Allan","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.mehy.2020.109863_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-10-122","article-title":"S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells","volume":"10","author":"Arnold","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.mehy.2020.109863_b0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/15384101.2015.1121324","article-title":"Inhibitory leukocyte immunoglobulin-like receptors: immune checkpoint proteins and tumor sustaining factors","volume":"15","author":"Kang","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mehy.2020.109863_b0190","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/sj.onc.1202552","article-title":"Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1","volume":"18","author":"Maeda","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.mehy.2020.109863_b0195","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.187.8.1355","article-title":"Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal","volume":"187","author":"Maeda","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2020.109863_b0200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","article-title":"Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy","volume":"19","author":"Barkal","year":"2017","journal-title":"Nat Immunol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698772030623X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698772030623X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:22:27Z","timestamp":1759692147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698772030623X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"alternative-id":["S030698772030623X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109863","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukocyte immunoglobulin-like receptor subfamily B member 1 potentially acts as a diagnostic and prognostic target in certain subtypes of adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109863"}}